Drug Type Small molecule drug |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Azura Ophthalmics Pty Ltd.Startup |
Active Organization Azura Ophthalmics Pty Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Blepharokeratoconjunctivitis | Preclinical | IL | Azura Ophthalmics Pty Ltd.Startup | 05 Dec 2023 |